Cita APA

Sato, T., Nishimura, K., Nozawa, T., Kanetaka, T., Kikuchi, M., Hara, R., . . . Yokota, S. (2013). PReS-FINAL-2110: Tocilizumab for patients with oligoarticular juvenile idiopathic arthritis refractory to conventional therapy. BioMed Central.

Chicago Style Citation

Sato, T., et al. PReS-FINAL-2110: Tocilizumab for Patients With Oligoarticular Juvenile Idiopathic Arthritis Refractory to Conventional Therapy. BioMed Central, 2013.

Cita MLA

Sato, T., et al. PReS-FINAL-2110: Tocilizumab for Patients With Oligoarticular Juvenile Idiopathic Arthritis Refractory to Conventional Therapy. BioMed Central, 2013.